使用血清表面活性蛋白-D,KL-6进行肺纤维化查,并在胸部放射图上使用深度学习算法:一项前性观察性研究
Hirotaka Nishikiori1, Naoya Yama2, Kenichi Hirota3
1Department of Respiratory Medicine and Allergology, Sapporo Medical University School of Medicine, South 1-West 16, Chuo-ku, Sapporo, Hokkaido, 0608543, Japan. hnishiki@sapmed.ac.jp.
BMC pulmonary medicine
|December 17, 2025
概括
早期检测肺纤维化是一个挑战. 血清生物标志物表面活性蛋白-D (SP-D) 和KL-6,以及人工智能软件BMAX,在健康检查中有望识别肺纤维化.
科学领域:
- 肺部医学 肺部医学
- 放射学 放射学是一门学科.
- 生物标志物发现发现
背景情况:
- 早期识别肺纤维化是困难的,限制了及时干预.
- 血清生物标志物表面活性蛋白-D (SP-D) 和KL-6用于间歇性肺病 (ILD),但它们在早期纤维化检测中的作用尚不清楚.
- 胸部放射和深度学习软件 (BMAX) 正在探索在健康检查中早期检测肺纤维化.
研究的目的:
- 评估SP-D,KL-6和BMAX在常规健康检查期间检测肺纤维化的有效性.
- 为了比较这些标记物的灵敏度和特异性与CT确认的肺纤维化.
主要方法:
- 招募了2,751名接受健康检查的个人.
- 评估了胸部放射,SP-D和KL-6水平;高水平或异常导致CT扫描.
- 深度学习软件BMAX分析了纤维化X射线图,性能与使用CT结果的SP-D和KL-6相比.
主要成果:
- 在接受CT的81名参与者中,有8人确诊肺纤维化.
- SP-D和BMAX显示出100%的灵敏度,而KL-6显示出75%的灵敏度.
- BMAX实现了90.4%的特异性,优于SP-D (31.5%) 和KL-6 (75.3%).
结论:
- 在健康检查中,SP-D和KL-6显示出作为肺纤维化敏感查生物标志物的潜力.
- 作为一个准确的,独立的工具,BMAX在胸部X射线图上检测肺纤维化.
相关概念视频
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
Pulmonary Function Tests
Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...


